Serum cholinesterase activity following pancuronium and antagonism with neostigmine or pyridostigmine. 1976

R K Stoelting

UI MeSH Term Description Entries
D009388 Neostigmine A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier. Synstigmin,Neostigmine Bromide,Neostigmine Methylsulfate,Polstigmine,Proserine,Prostigmin,Prostigmine,Prozerin,Syntostigmine,Bromide, Neostigmine,Methylsulfate, Neostigmine
D010197 Pancuronium A bis-quaternary steroid that is a competitive nicotinic antagonist. As a neuromuscular blocking agent it is more potent than CURARE but has less effect on the circulatory system and on histamine release. Pancuronium Bromide,Pancuronium Curamed,Pancuronium Organon,Pavulon,Bromide, Pancuronium
D011729 Pyridostigmine Bromide A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants. Mestinon,Pyridostigmine,Bromide, Pyridostigmine
D002802 Cholinesterases Acylcholineacylhydrolase,Cholase,Cholinesterase

Related Publications

R K Stoelting
January 1982, Canadian Anaesthetists' Society journal,
R K Stoelting
May 1982, Canadian Anaesthetists' Society journal,
R K Stoelting
October 1989, Middle East journal of anaesthesiology,
R K Stoelting
August 1981, British journal of anaesthesia,
R K Stoelting
November 1987, Canadian journal of anaesthesia = Journal canadien d'anesthesie,
Copied contents to your clipboard!